JPH048034B2 - - Google Patents

Info

Publication number
JPH048034B2
JPH048034B2 JP58131097A JP13109783A JPH048034B2 JP H048034 B2 JPH048034 B2 JP H048034B2 JP 58131097 A JP58131097 A JP 58131097A JP 13109783 A JP13109783 A JP 13109783A JP H048034 B2 JPH048034 B2 JP H048034B2
Authority
JP
Japan
Prior art keywords
capsule
cells
living cells
albumin
wall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58131097A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6025929A (ja
Inventor
Aaru Taisu Toomasu
Ii Meiaazu Uiriamu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stolle Research and Development Corp
Original Assignee
Stolle Research and Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Research and Development Corp filed Critical Stolle Research and Development Corp
Priority to JP58131097A priority Critical patent/JPS6025929A/ja
Publication of JPS6025929A publication Critical patent/JPS6025929A/ja
Publication of JPH048034B2 publication Critical patent/JPH048034B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP58131097A 1983-07-20 1983-07-20 カプセル化細胞、その製造方法および用途 Granted JPS6025929A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58131097A JPS6025929A (ja) 1983-07-20 1983-07-20 カプセル化細胞、その製造方法および用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58131097A JPS6025929A (ja) 1983-07-20 1983-07-20 カプセル化細胞、その製造方法および用途

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP3287274A Division JPH0685711B2 (ja) 1991-10-08 1991-10-08 細胞の繁殖方法

Publications (2)

Publication Number Publication Date
JPS6025929A JPS6025929A (ja) 1985-02-08
JPH048034B2 true JPH048034B2 (cs) 1992-02-13

Family

ID=15049904

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58131097A Granted JPS6025929A (ja) 1983-07-20 1983-07-20 カプセル化細胞、その製造方法および用途

Country Status (1)

Country Link
JP (1) JPS6025929A (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69725754T2 (de) * 1996-12-23 2004-08-19 Centre National De La Recherche Scientifique Eingekapselte Antikörper-produzierende Zellen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
NO161446C (no) * 1981-03-13 1989-08-16 Damon Biotech Inc Fremgangsmaate for dyrking av celler som er avhengige av forankring.
NO163060C (no) * 1981-03-13 1990-03-28 Damon Biotech Inc Fremgangsmaate for fremstilling av substanser som dannes av levende celler som produserer interferoner eller antistoffer.

Also Published As

Publication number Publication date
JPS6025929A (ja) 1985-02-08

Similar Documents

Publication Publication Date Title
US4798786A (en) Living cells encapsulated in crosslinked protein
US4391909A (en) Microcapsules containing viable tissue cells
US4352883A (en) Encapsulation of biological material
JP3524096B2 (ja) 水性媒体において膜をゲル化粒子の少なくとも表面に形成するためのエステル化多糖とポリアミンとの間のアシル交換反応の使用、それにより生成した粒子、それらの製造方法及び前記粒子を含有する組成物
Chang Therapeutic applications of polymeric artificial cells
Colton et al. Bioengineering in development of the hybrid artificial pancreas
US4004979A (en) Preparation of active proteins cross-linked to inactive proteins
Chang Artificial cells with emphasis on bioencapsulation in biotechnology
Uludag et al. Technology of mammalian cell encapsulation
Chang ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology
CA1174600A (en) Encapsulation of live animal cells
JPS6244919B2 (cs)
JPH11501514A (ja) 新規の封入組成物及び封入方法
JPS58500063A (ja) ペレット、微小ビ−ド、微小カプセルおよびそれらの製法
Chang Pharmaceutical and therapeutic applications of artificial cells including microencapsulation
Chang Artificial cells in medicine and biotechnology
EP0129619B1 (en) Encapsulated cells, their method of preparation and use
Lu et al. Cell encapsulation with alginate and α‐phenoxycinnamylidene‐acetylated poly (allylamine)
Wang Development of new polycations for cell encapsulation with alginate
Chang et al. Artificial cells for bioencapsulation of cells and genetically engineered E. coli: for cell therapy, gene therapy, and removal of urea and ammonia
WO1988000237A1 (en) Covalent membranes
JPH048034B2 (cs)
Chang Bioencapsulation in biotechnology
Chang Artificial cells in immobilization biotechnology
Freitag Synthetic polymers for biotechnology and medicine